India | Imports and Exports | World | Hormones, prostaglandins, thromboxanes and leukotrienes, derivatives and structural analogues thereof | Value (US$) and Value Growth, YoY (%) | 2012 - 2023
The value of exports of commodity group 2937 "Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones" from India totalled $ 303 million in 2023. Sales of commodity group 2937 from India went up by 14.3% compared to 2022: exports of commodity group 2937 "Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones" went up by $ 37 million (cumulative exports of commodity group 2937 from India amounted $265 million in 2022)
Exports of commodity group 2937 "Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones" amounted to 0.07% of total exports from India (cumulative merchandise exports from India totalled $ 431 billion in 2023). The share of commodity group 2937 in total exports from India increased by 0.011 p.p. compared to 2022 (it was 0.058% in 2022 and cumulative exports from India were equal to $ 452 billion).
Exports of commodity group 2937 amounted to 1.55% of total sales of group "" from India in 2023 (the value of exports of commodity group from India amounted to $19.4 billion in 2023). The share of exports of commodity group 2937 in sales of commodity group from India increased by 0.344 p.p. compared to 2022 (it was 1.21% in 2022, and exports of commodity group from India were $21 billion).
Where does India export Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones?
Top export destinations of "Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones" from India in 2023:
- Russia with a share of 10.5% (31 million US$)
- USA with a share of 8.62% (26 million US$)
- Netherlands with a share of 8.29% (25 million US$)
- Mexico with a share of 6.29% (19 million US$)
- Belgium with a share of 4.99% (15.1 million US$)
- Ireland with a share of 3.88% (11.7 million US$)
- Japan with a share of 3.58% (10.8 million US$)
- Bangladesh with a share of 3.46% (10.5 million US$)
- United Arab Emirates with a share of 3.3% (10 million US$)
- Pakistan with a share of 3.26% (9.88 million US$)
Exports structure of 2937 - Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones - from India in 2023 represented by the following main commodity groups:
- 36% (110 million US$): 293729 - Steroidal hormones, their derivatives & structural analogues (excl. of 2937.21-2937.23)
- 18.3% (55 million US$): 293790 - Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones, n.e.c. in heading 2937
- 13.6% (41 million US$): 293712 - Insulin & its salts
- 10.3% (31 million US$): 293722 - Halogenated derivatives of corticosteroidal hormones
- 10.1% (30 million US$): 293719 - Polypeptide hormones, protein hormones & glycoprotein hormones, their derivatives & structural analogues (excl. of 2937.11 & 2937.12)
- 6.42% (19.4 million US$): 293723 - Oestrogens & progestogens
- 3.87% (11.7 million US$): 293721 - Cortisone, hydrocortisone, prednisone (dehydrocortisone) & prednisolone (dehydrohydrocortisone)
- 0.73% (2.21 million US$): 293750 - Prostaglandins, thromboxanes & leukotrienes, their derivatives & structural analogues
- 0.103% (312 thousand US$): 293711 - Somatotropin, its derivatives & structural analogues
The value of imports of commodity group 2937 "Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones" to India totalled $ 382 million in 2023. Sales of commodity group 2937 to India went up by 6.73% compared to 2022: imports of commodity group 2937 "Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones" went up by $ 24 million (the value of imports of commodity group 2937 to India was equal to $358 million in 2022)
Imports of commodity group 2937 "Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones" accounted for 0.056% of total import flow to India (in 2023, total imports to India amounted to $ 672 billion). The share of commodity group 2937 in total imports to India increased by 0.007 p.p. compared to 2022 (it was 0.048% in 2022 and cumulative imports to India were equal to $ 732 billion).
Imports of commodity group 2937 reached 1.4% of total imports of group "" to India in 2023 (imports of commodity group to India totalled $27 billion in 2023). The share of purchases of commodity group 2937 in total imports of commodity group to India increased by 0.201 p.p. compared to 2022 (it was 1.2% in 2022, and imports of commodity group to India accounted for $29 billion).
Where does India import Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones from?
Top trading partners (import of "Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones") of India in 2023:
- China with a share of 61% (235 million US$)
- Italy with a share of 9.51% (36 million US$)
- Denmark with a share of 5.19% (19.8 million US$)
- Germany with a share of 3.98% (15.2 million US$)
- Netherlands with a share of 3.82% (14.6 million US$)
- USA with a share of 3.11% (11.9 million US$)
- Mexico with a share of 3.03% (11.6 million US$)
- Spain with a share of 2.02% (7.73 million US$)
- Malaysia with a share of 1.41% (5.41 million US$)
- Switzerland with a share of 1.33% (5.09 million US$)
Imports structure of 2937 - Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones - to India in 2023 represented by the following main commodity groups:
- 32% (123 million US$): 293729 - Steroidal hormones, their derivatives & structural analogues (excl. of 2937.21-2937.23)
- 17.3% (66 million US$): 293790 - Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones, n.e.c. in heading 2937
- 14.3% (55 million US$): 293723 - Oestrogens & progestogens
- 10.9% (41 million US$): 293721 - Cortisone, hydrocortisone, prednisone (dehydrocortisone) & prednisolone (dehydrohydrocortisone)
- 8.75% (33 million US$): 293719 - Polypeptide hormones, protein hormones & glycoprotein hormones, their derivatives & structural analogues (excl. of 2937.11 & 2937.12)
- 8.38% (32 million US$): 293712 - Insulin & its salts
- 6.83% (26 million US$): 293722 - Halogenated derivatives of corticosteroidal hormones
- 1.09% (4.2 million US$): 293750 - Prostaglandins, thromboxanes & leukotrienes, their derivatives & structural analogues
- 0.004% (18.5 thousand US$): 293711 - Somatotropin, its derivatives & structural analogues
